News

Jul 15, 2020

EDAP Announces Recent Focal One Sales Successes

Company completes four Focal One sales, including three bundled sales that combine Focal One® with Exact Imaging’s ExactVu micro ultrasound imaging solution.

May 12, 2020

EDAP announces exclusive worldwide distribution rights to EXACT Imaging's Micro-Ultrasound Technologies

Apr 23, 2020

B Riley FBR Initiates Research Coverage on EDAP TMS

Last week Andrew D’Silva of B Riley FBR launched research coverage on EDAP TMS with a buy-rating and price target at $5.50. Read more

Mar 17, 2020

EDAP TMS about COVID-19

Update on COVID-19 and the Potential Impact to Operations

Apr 1, 2019

Focal One's precision means qualifying prostate cancer patients can forego prostate removal surgery and avoid life-altering side effects including incontinence and impotence

The University of Chicago Medicine became the first medical center in the Midwest to offer focal therapy to men with localized prostate cancer, using Focal One, the only advanced robotic ultrasound technology available to target and ablate diseased prostate tissue.

Mar 4, 2019

Houston Methodist's Reinforces EDAP's Position as a Leading HIFU Innovator

Houston Methodist Hospital, has acquired Focal One®, the most advanced HIFU technology available today

Jan 23, 2019

Maimonides Medical Center acquires Focal One Technology

Jan 14, 2019

Two additional Focal One devices to two leading hospitals in Brazil

Hospital 9 de Julho and Hospital Moriah join growing roster of highly-regarded hospitals in Brazil offering Focal One

Jan 3, 2019

John Wayne Cancer Institute First US Medical Center to Acquire EDAP's Breakthrough Focal One Technology for Prostate Tissue Ablation

John Wayne Cancer Institute (JWCI) at the Providence Saint John's Health Center in Santa Monica, offer focal therapy to patients with localized prostate cancer using Focal One

Dec 12, 2018

Oncology Live - Urologists in Cancer Care

Focal Therapy Evolves Into More Precise Treatment